Compare Cadila Healthcare with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DIVIS LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DIVIS LABORATORIES CADILA HEALTHCARE/
DIVIS LABORATORIES
 
P/E (TTM) x 29.7 56.1 53.0% View Chart
P/BV x 6.1 15.2 40.2% View Chart
Dividend Yield % 0.6 0.4 147.9%  

Financials

 CADILA HEALTHCARE   DIVIS LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
DIVIS LABORATORIES
Mar-20
CADILA HEALTHCARE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3522,258 15.6%   
Low Rs2071,467 14.1%   
Sales per share (Unadj.) Rs139.2203.2 68.5%  
Earnings per share (Unadj.) Rs11.551.9 22.1%  
Cash flow per share (Unadj.) Rs18.358.9 31.1%  
Dividends per share (Unadj.) Rs3.5016.00 21.9%  
Dividend yield (eoy) %1.30.9 145.8%  
Book value per share (Unadj.) Rs101.4275.4 36.8%  
Shares outstanding (eoy) m1,023.74265.47 385.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.09.2 21.9%   
Avg P/E ratio x24.335.9 67.7%  
P/CF ratio (eoy) x15.331.6 48.3%  
Price / Book Value ratio x2.86.8 40.8%  
Dividend payout %30.530.9 98.8%   
Avg Mkt Cap Rs m286,034494,429 57.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,8856,211 352.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m142,53153,944 264.2%  
Other income Rs m1,1711,896 61.8%   
Total revenues Rs m143,70255,841 257.3%   
Gross profit Rs m24,16618,232 132.5%  
Depreciation Rs m6,9651,862 374.0%   
Interest Rs m3,41871 4,787.1%   
Profit before tax Rs m14,95418,195 82.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1984,429 72.2%   
Profit after tax Rs m11,75613,765 85.4%  
Gross profit margin %17.033.8 50.2%  
Effective tax rate %21.424.3 87.8%   
Net profit margin %8.225.5 32.3%  
BALANCE SHEET DATA
Current assets Rs m87,15455,735 156.4%   
Current liabilities Rs m82,69418,205 454.2%   
Net working cap to sales %3.169.6 4.5%  
Current ratio x1.13.1 34.4%  
Inventory Days Days3576 45.9%  
Debtors Days Days94956 9.8%  
Net fixed assets Rs m141,18338,515 366.6%   
Share capital Rs m1,024531 192.9%   
"Free" reserves Rs m102,73372,568 141.6%   
Net worth Rs m103,75773,099 141.9%   
Long term debt Rs m32,1460-   
Total assets Rs m228,33794,250 242.3%  
Interest coverage x5.4255.8 2.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.6 109.1%   
Return on assets %6.614.7 45.3%  
Return on equity %11.318.8 60.2%  
Return on capital %13.525.0 54.1%  
Exports to sales %00-   
Imports to sales %10.221.5 47.3%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m14,50411,597 125.1%   
Fx inflow Rs m52,75244,832 117.7%   
Fx outflow Rs m14,50411,837 122.5%   
Net fx Rs m38,24832,996 115.9%   
CASH FLOW
From Operations Rs m25,05412,159 206.0%  
From Investments Rs m-10,123-835 1,212.8%  
From Financial Activity Rs m-10,942-10,914 100.3%  
Net Cashflow Rs m3,989411 971.7%  

Share Holding

Indian Promoters % 74.9 52.0 144.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 36.6 45.2%  
FIIs % 5.2 19.9 26.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 48.1 52.3%  
Shareholders   223,384 208,203 107.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   EMMESSAR CHM  BROOKS LAB  VENUS REMEDIES  HIKAL.  BERYL DRUGS  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover from Day's Low to End Flat; Adani Ports and Bajaj Auto Among Top Gainers(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session on a flat note.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 18, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS